Early response evaluation and CEA response in patients treated in a Danish randomized study comparing trifluridine/tipiracil (TAS-102) with or without bevazicumab in patients with chemorefractory metastatic colorectal cancer (mCRC)

医学 贝伐单抗 伊立替康 奥沙利铂 结直肠癌 内科学 随机对照试验 耐火材料(行星科学) 肿瘤科 化疗 胃肠病学 癌症 物理 天体生物学
作者
Camilla Qvortrup,Melih Yilmaz,Sören Möller,Daniela Žitnjak,L. Maltha,Merete Krogh,Lone N. Petersen,Finn Hejlesen,Stine Brændegaard Winther,Karina Gravgaard Thomsen,Per Pfeiffer
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:30: v233-v233
标识
DOI:10.1093/annonc/mdz246.094
摘要

Abstract Background Trifluridine/tipiracil (FTD/TPI, also known as TAS-102) prolongs OS in patients with chemorefractory mCRC. Inspired by the results of C-TASK FORCE (Kuboki 2017), we designed an investigator-initiated randomized trial in the last setting in mCRC patients demonstrating improved PFS and OS in patients receiving bevazicumab combined with TAS-102 as compared to patients treated with TAS-102 alone (Pfeiffer WCGI 2019). In the last line setting half of patients will not benefit from therapy as they have PD at the first evaluation performed after 2 months of therapy. In the present study we included an early response evaluation after 1 month of therapy aiming to identify patients not having any effect of therapy. In addition, we evaluated plasma CEA as a marker of response. Methods The main inclusion criteria were: histologically confirmed and chemo-refractory mCRC; PD during or after therapy with FU, irinotecan, oxaliplatin, and EGFR-inhibitor (RASwt); prior treatment with bevacizumab was allowed; PS 0-1. In arm A: FTD/TPI 35 mg/m²/dose bid from days 1-5 and 8-12; in arm B the same dose of FTD/TPI with bevacizumab (5 mg/kg), days 1 and 15 of a 28-day cycle. Response evaluation performed during treatment at 4 weeks, 8 weeks, and every 8 weeks thereafter. CEA was tested at baseline and at every 2. cycle. Results 93 patients with chemo-refractory mCRC were randomized from Sep. 2017 to Oct. 2018. The median PFS was significantly improved from 2.6 months (arm A) to 4.6 months (arm B) with a HR 0.45 (95% CI, 0.29-0.72; P = 0.001). Median OS was significantly prolonged from 6.7 months (arm A) to 9.4 months (arm B) with HR 0.55 (95% CI, 0.32-0.94; P = 0.03) (Pfeiffer WCGI 2019). Sub-group analyses including predictive markers for early progression will presented. Conclusions FTD/TPI in combination with bevacizumab prolong PFS and OS and is a new option in patients with chemo-refractory mCRC. Predictive markers for early progression are ongoing and will be presented. Clinical trial identification 2016-005241-23. Legal entity responsible for the study Per Pfeiffer. Funding Servier. Disclosure C. Qvortrup: Research grant / Funding (institution): Servier. P. Pfeiffer: Research grant / Funding (institution): Servier; Research grant / Funding (institution): Merck. All other authors have declared no conflicts of interest.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
兔兔完成签到 ,获得积分10
4秒前
大气小天鹅完成签到 ,获得积分10
13秒前
陈秋完成签到,获得积分10
14秒前
风清扬发布了新的文献求助10
17秒前
发个15分的完成签到 ,获得积分10
19秒前
melody完成签到 ,获得积分10
23秒前
地表飞猪完成签到,获得积分0
23秒前
天将明完成签到 ,获得积分10
24秒前
25秒前
酷酷一笑发布了新的文献求助10
30秒前
cheng完成签到 ,获得积分10
30秒前
yanjiuhuzu完成签到,获得积分10
39秒前
tengyve完成签到,获得积分10
52秒前
酷炫蛋挞完成签到 ,获得积分10
53秒前
candy6663339完成签到,获得积分10
53秒前
回首不再是少年完成签到,获得积分0
55秒前
酷酷一笑完成签到,获得积分10
57秒前
天天快乐应助科研通管家采纳,获得10
1分钟前
isedu完成签到,获得积分10
1分钟前
U9A完成签到,获得积分10
1分钟前
一亩蔬菜完成签到,获得积分10
1分钟前
Lucas应助科研人一枚采纳,获得10
1分钟前
hi完成签到,获得积分10
1分钟前
快乐的芷巧完成签到,获得积分10
1分钟前
酷酷小子完成签到 ,获得积分10
1分钟前
1分钟前
巴山完成签到,获得积分10
1分钟前
无花果应助ly采纳,获得10
1分钟前
loren313完成签到,获得积分0
1分钟前
玄学小生完成签到 ,获得积分10
1分钟前
小梦完成签到,获得积分10
1分钟前
白桃完成签到 ,获得积分10
1分钟前
王世卉完成签到,获得积分10
1分钟前
湖以完成签到 ,获得积分10
1分钟前
清脆的靖仇完成签到,获得积分10
1分钟前
lixiaoya完成签到,获得积分10
1分钟前
小洪俊熙完成签到,获得积分10
1分钟前
nicolaslcq完成签到,获得积分10
1分钟前
研友_Z119gZ完成签到 ,获得积分10
2分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968559
求助须知:如何正确求助?哪些是违规求助? 3513358
关于积分的说明 11167340
捐赠科研通 3248714
什么是DOI,文献DOI怎么找? 1794453
邀请新用户注册赠送积分活动 875065
科研通“疑难数据库(出版商)”最低求助积分说明 804664